Scroll to Top
/ Press Releases & Statements
Press Releases & Statements
EFPIA – IFPMA Statement in response to the OECD Health Committee Ministerial Statement
17 January 2017
We welcome the Ministerial Statement from the OECD Health Committee, which seeks to address many important issues for health systems in OECD countries. Reducing waste ...
Europe must remain the world leader in excellent and responsible biomedical research
06 December 2016
In line with Directive 2010/63 on the protection of laboratory animals, the pharmaceutical industry, which, together with other life science players, develops continuously new scientific ...
EFPIA opinion on the Annual Growth Survey and recommendations for the European Semester 2017
23 November 2016
EFPIA welcomes the publication by the European Commission of the Annual Growth Survey, starting off the European Semester Cycle for 2017. EFPIA agrees with the three ...
EFPIA Response to Publication of “The Trial Tracker”
04 November 2016
We have not yet had the opportunity to analyse this specific study, yet we nevertheless welcome the continued focus on clinical trial transparency brought by ...
EFPIA Welcomes Second EUIPO/EPO Report As Clear Evidence of IPR-Intensive Industries' Significant Value to the EU Economy
25 October 2016
EFPIA welcomes the publication of the European Union Intellectual Property Office (EUIPO) and European Patent Office (EPO) joint report on the value of intellectual property ...
EFPIA and EBE Welcome NOR-SWITCH Results as a Valuable Step Forward
19 October 2016
EFPIA and EBE welcome the results of the NOR-SWITCH study on biosimilar switching* and acknowledge its preliminary results as a step in the right direction ...
EFPIA Statement on the ENVI Committee’s Draft Report on EU Options for Improving Access to Medicines
06 October 2016
EFPIA notes the publication of the European Parliament’s ENVI Committee draft report on EU options for improving access to medicines. People all over Europe are living ...
EFPIA Backs Report Renewing Efforts to Tackle the Scourge of Counterfeit Medicines
29 September 2016
EFPIA welcomes the publication by the European Observatory on Infringements of Intellectual Property Rights of a new report assessing the economic impact of counterfeiting and piracy in ...
EFPIA Statement on the UN HLP Report on Access to Medicines
14 September 2016
EFPIA acknowledges the publication of the UN High Level Panel’s (UN HLP’s) report on access to medicines. However, EFPIA believes the report represents a missed ...
EFPIA Statement on the European Court of Justice Lundbeck Ruling
08 September 2016
EFPIA regrets the General Court of the European Union’s decision to uphold the European Commission’s classification of the Lundbeck patent settlement agreements as restrictions of competition “by ...
Page 2 of 21
Press Releases & Statements
Enabling Technologies for Better Patient Outcomes - Live Streaming
Facts & Figures
Follow us on
Add us on
Check us out on
EFPIA Brussels Office
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
European Biopharmaceutical Enterprises
INNOVATIVE MEDICINES INITIATIVE
Educational Events & Ethical Evaluation
EFPIA 2017 - All rights reserved -
- Design by
Morris & Chapman